Cozad Asset Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.82M | Sell |
7,768
-260
| -3% | -$141K | 0.3% | 81 |
|
|
2025
Q4 | $4.65M | Buy |
8,028
+370
| +5% | +$209K | 0.36% | 69 |
|
|
2025
Q3 | $3.71M | Buy |
7,658
+197
| +3% | +$91.7K | 0.3% | 84 |
|
|
2025
Q2 | $3.03M | Sell |
7,461
-2,114
| -22% | -$884K | 0.26% | 96 |
|
|
2025
Q1 | $4.76M | Sell |
9,575
-830
| -8% | -$450K | 0.48% | 58 |
|
|
2024
Q4 | $5.41M | Sell |
10,405
-568
| -5% | -$312K | 0.5% | 49 |
|
|
2024
Q3 | $6.79M | Buy |
10,973
+6
| +0.1% | +$3.55K | 0.65% | 40 |
|
|
2024
Q2 | $6.06M | Buy |
10,967
+382
| +4% | +$219K | 0.61% | 43 |
|
|
2024
Q1 | $6.15M | Sell |
10,585
-1,892
| -15% | -$1.06M | 0.64% | 40 |
|
|
2023
Q4 | $6.62M | Sell |
12,477
-1,289
| -9% | -$624K | 0.76% | 36 |
|
|
2023
Q3 | $6.97M | Sell |
13,766
-1,676
| -11% | -$893K | 0.91% | 26 |
|
|
2023
Q2 | $8.06M | Sell |
15,442
-2,330
| -13% | -$1.26M | 1.01% | 23 |
|
|
2023
Q1 | $10.2M | Sell |
17,772
-206
| -1% | -$116K | 1.36% | 13 |
|
|
2022
Q4 | $9.9M | Sell |
17,978
-372
| -2% | -$197K | 1.39% | 10 |
|
|
2022
Q3 | $9.31M | Sell |
18,350
-1,723
| -9% | -$964K | 1.51% | 10 |
|
|
2022
Q2 | $10.9M | Buy |
20,073
+1,037
| +5% | +$571K | 1.7% | 6 |
|
|
2022
Q1 | $11.2M | Buy |
19,036
+1,494
| +9% | +$858K | 1.57% | 11 |
|
|
2021
Q4 | $11.7M | Sell |
17,542
-1,015
| -5% | -$634K | 1.66% | 8 |
|
|
2021
Q3 | $10.6M | Sell |
18,557
-230
| -1% | -$126K | 1.65% | 8 |
|
|
2021
Q2 | $9.48M | Sell |
18,787
-569
| -3% | -$268K | 1.49% | 12 |
|
|
2021
Q1 | $8.83M | Buy |
19,356
+97
| +0.5% | +$46.3K | 1.44% | 12 |
|
|
2020
Q4 | $8.97M | Sell |
19,259
-1,282
| -6% | -$601K | 1.6% | 7 |
|
|
2020
Q3 | $9.07M | Sell |
20,541
-723
| -3% | -$299K | 1.71% | 7 |
|
|
2020
Q2 | $7.71M | Sell |
21,264
-1,517
| -7% | -$508K | 1.57% | 9 |
|
|
2020
Q1 | $6.46M | Sell |
22,781
-552
| -2% | -$174K | 2.23% | 7 |
|
|
2019
Q4 | $7.58M | Sell |
23,333
-612
| -3% | -$186K | 2.02% | 5 |
|
|
2019
Q3 | $6.97M | Sell |
23,945
-280
| -1% | -$80.2K | 2.01% | 4 |
|
|
2019
Q2 | $7.11M | Sell |
24,225
-952
| -4% | -$262K | 2.06% | 4 |
|
|
2019
Q1 | $6.89M | Buy |
25,177
+379
| +2% | +$94.3K | 2.08% | 4 |
|
|
2018
Q4 | $5.55M | Buy |
24,798
+188
| +0.8% | +$44.1K | 1.92% | 6 |
|
|
2018
Q3 | $6.01M | Buy |
24,610
+125
| +0.5% | +$28.8K | 1.76% | 11 |
|
|
2018
Q2 | $5.07M | Buy |
+24,485
| New | +$5.2M | 1.58% | 13 |
|
Other funds holding TMO
VCM
Cozad Asset Management's TMO Position: Q1 2026 in Review
Cozad Asset Management reduced its Thermo Fisher Scientific (TMO) stake by 3.2% in Q1 2026, selling an estimated $141K and leaving 7,768 shares worth $3.82M. The position accounts for 0.3% of the portfolio, ranked #81.
Cozad Asset Management first reported a position in TMO in Q2 2018 and has held it in 32 quarters since. The position peaked at $11.7M in Q4 2021. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Cozad Asset Management held 7,768 shares of Thermo Fisher Scientific worth $3.82M as of Q1 2026.
- Cozad Asset Management sold 260 Thermo Fisher Scientific shares in Q1 2026, an estimated $141K.
- Thermo Fisher Scientific made up 0.3% of Cozad Asset Management's portfolio in Q1 2026, its #81 holding.
- Cozad Asset Management first reported a position in Thermo Fisher Scientific in Q2 2018 and has held it in 32 quarters since.
- Cozad Asset Management's Thermo Fisher Scientific position peaked at $11.7M in Q4 2021.
- 2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Cozad Asset Management's 13F filing for Q1 2026, filed 28 May 2026.